ArticleBreast cancer research and treatment2020

Correction to: Pharmacokinetic and pharmacodynamic analysis of fulvestrant in preclinical models of breast cancer to assess the importance of its estrogen receptor-α degrader activity in antitumor efficacy.

Suzanne E Wardell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.